Letter Written in Response to van Bon et al.: “Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial”

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Diabetes Technology & Therapeutics

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/dia.2011.0122PMID 21732826PMCID PMC3136718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial

  2011influential reference
• Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes.

  2006cited by this paper

• Glycemic Management Across the Lifespan for People With Type 1 Diabetes: A Clinical Practice Guideline.

  2025cites this paper
• Trends in baseline HbA1c and body-mass index in randomised trials of people with type 1 diabetes from 1993 to 2025: an IMI2 SOPHIA systematic review and meta-analysis

  2025cites this paper
• Biosimilar insulins: Narrative review of the regulatory framework and registration studies

  2025cites this paper
• Current and Future Strategies in Insulin Development and Treatment

  2024cites this paper
• Supervised and Unsupervised Approaches for the Real-Time Detection of Undesired Insulin Suspension Caused by Malfunctions

  2024cites this paper
• Does the Type of Cannula Matter? A Case Report and Review of the Evidence Regarding Steel and Plastic Cannulae With Respect to a Continuous Subcutaneous Insulin Infusion

  2024cites this paper
• New Insulins, Biosimilars, and Insulin Therapy

  2023cites this paper
• Monitoring Statistical Properties of Kalman Filter Residuals in an Artificial Pancreas to Detect Overnight Pump Malfunctions Causing Insulin Suspension

  2023cites this paper
• Development of the Extended Infusion Set and Its Mechanism of Action

  2022cites this paper
• Efficacy and safety of ultra-rapid insulin analogues in insulin pumps in patients with Type 1 Diabetes Mellitus: A systematic review and meta-analysis.

  2022cites this paper
• Scientific advisory on nocturnal hypoglycemia in insulin-treated patients with diabetes: Recommendations from Indian experts.

  2022cites this paper
• A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes

  2022cites this paper
• A Comprehensive Review of the Evolution of Insulin Development and Its Delivery Method

  2022cites this paper
• In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time

  2022cites this paper
• Feasibility study of a prototype extended‐wear insulin infusion set in adults with type 1 diabetes

  2022cites this paper
• Proteomic Changes to the Updated Discovery of Engineered Insulin and Its Analogs: Pros and Cons

  2022cites this paper
• The automated pancreas: A review of technologies and clinical practice

  2021cites this paper
• Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review

  2020cites this paper
• Evolution and Comparison Effects of Fludrocortisone and Betamethasone on Glucose and Lipid Profile in Rats

  2020cites this paper
• Improving the treatment of patients with diabetes using insulin analogues: current findings and future directions

  2020cites this paper
• Comparative effects of insulin glulisine and lispro on postprandial plasma glucose and lipid profile in Japanese patients with type 2 diabetes mellitus

  2020cites this paper
• Data-Driven Anomaly Recognition for Unsupervised Model-Free Fault Detection in Artificial Pancreas

  2020cites this paper
• Model-Based Detection and Classification of Insulin Pump Faults and Missed Meal Announcements in Artificial Pancreas Systems for Type 1 Diabetes Therapy

  2020cites this paper
• Insulin under the influence of light.

  2020cites this paper
• Investigation of factors that cause insulin precipitation and/or amyloid formation in insulin formulations

  2019cites this paper
• Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial

  2019influential citation
• Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis

  2019cites this paper
• A Model‐Informed Drug Discovery and Development Strategy for the Novel Glucose‐Responsive Insulin MK‐2640 Enabled Rapid Decision Making

  2019cites this paper
• In vivo investigation of the tissue response to commercial Teflon insulin infusion sets in large swine for 14 days: the effect of angle of insertion on tissue histology and insulin spread within the subcutaneous tissue

  2019cites this paper
• Therapeutic Class Overview Insulin and Combination Agents

  2019cites this paper
• COMPARISON OF INSULIN GLARGINE AND GLULISINE WITH INSULIN NPH AND REGULAR FOR GLYCEMIC CONTROL IN CHILDREN WITH TYPE –I DIABETES MELLITUS

  2019cites this paper
• Detection of Insulin Pump Malfunctioning to Improve Safety in Artificial Pancreas Using Unsupervised Algorithms

  2019cites this paper
• Fault Detection in Artificial Pancreas: A Model-Free approach

  2018cites this paper
• Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump

  2018cites this paper
• ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes

  2018cites this paper
• Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis

  2018influential citation
• A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus

  2018cites this paper
• Pump Users Clamor for Faster Insulin: Is Fast-Acting Insulin Aspart Ready for Them?

  2018cites this paper
• Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A Review

  2018cites this paper
• Innate Immune Cell Suppression and the Link With Secondary Lung Bacterial Pneumonia

  2018cites this paper
• Insulin pump breakdown and infusion set failure in Italian children with type 1 diabetes: A 1‐year prospective observational study with suggestions to minimize clinical impact

  2018cites this paper
• Moderne Therapie des Typ-1-Diabetes – Pumpentherapie mit Insulinanaloga

  2018cites this paper
• Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas

  2017cites this paper
• Moderne Therapie des Typ-1-Diabetes: Pumpentherapie mit Insulinanaloga – Indikationen, Daten zur Handhabung und Ausblicke

  2017influential citation
• Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block

  2017cites this paper
• Impact of targeted education on managing warning and error signals by children and adolescents with type 1 diabetes using the Accu-Chek Combo Insulin Pump System

  2017cites this paper
• Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life

  2017cites this paper
• Insulin Infusion Set Use: European Perspectives and Recommendations

  2016cites this paper
• Improving Patient Experience With Insulin Infusion Sets

  2016cites this paper
• Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies

  2016influential citation
• Moving toward the ideal insulin for insulin pumps

  2016influential citation
• Insulin Infusion Sets: A Critical Reappraisal

  2016cites this paper
• New Insulin Delivery Recommendations.

  2016cites this paper
• Clinical Outcomes After 1 Year of Augmented Insulin Pump Therapy in Patients with Diabetes in a Specialized Diabetes Center in Medellín, Colombia

  2016cites this paper
• Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience

  2015cites this paper
• Insulin aspart for the treatment of Type 2 diabetes

  2015cites this paper
• Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics

  2015influential citation
• Insulin Analogs Applied with Continuous Subcutaneous Insulin Infusion (Pump) in the Treatment of Diabetes

  2015cites this paper
• Insulin Lispro with Continuous Subcutaneous Insulin Infusion is Safe and Effective in Patients with Type 2 Diabetes: A Randomized Crossover Trial of Insulin Lispro Versus Insulin Aspart.

  2015cites this paper
• Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions

  2015cites this paper
• Clinical review: insulin pump-associated adverse events in adults and children

  2015cites this paper
• Glucose-responsive Implantable Polymeric Microdevices for “Smart” Insulin Therapy of Diabetes

  2014cites this paper
• Consensus evidence-based guidelines for use of insulin pump therapy in the management of diabetes as per Indian clinical practice.

  2014cites this paper
• Mathematical Model of Glucose-Insulin Metabolism in Type 1 Diabetes Including Digestion and Absorption of Carbohydrates

  2014cites this paper
• Phenolic excipients of insulin formulations induce cell death, pro-inflammatory signaling and MCP-1 release

  2014cites this paper
• ISPAD Clinical Practice Consensus Guidelines 2014 Compendium

  2014cites this paper
• Randomized Trial of Infusion Set Function: Steel Versus Teflon

  2014cites this paper
• Introduction to ISPAD Clinical Practice Consensus Guidelines 2014 Compendium

  2014cites this paper
• Impact of insulins glulisine and aspart on postprandial glycemia after a high-glycemic index meal in children with type 1 diabetes.

  2014cites this paper
• Chapter 42 - Insulin, other hypoglycemic drugs, and glucagon

  2014cites this paper
• Insulin treatment in children and adolescents with diabetes

  2014cites this paper
• Unexplained Hyperglycemia in a Patient on Insulin Pump Therapy: Transient Insulin Failure?

  2014cites this paper
• New Insulins and Insulin Therapy

  2013cites this paper
• Stability and Performance of Rapid-Acting Insulin Analogs Used for Continuous Subcutaneous Insulin Infusion: A Systematic Review

  2013cites this paper
• Comparison of the effect of insulin glulisine to insulin aspart on breakfast postprandial blood glucose levels in children with type 1 diabetes mellitus on multiple daily injections.

  2013cites this paper
• Advances in insulin therapy.

  2013cites this paper
• New guidelines for the use of insulin infusion pumps in South Africa: a welcome document which is well overdue

  2013cites this paper
• An overview of insulin pump therapy: appropriate use of an expensive resource

  2012cites this paper
• Accelerating and Improving the Consistency of Rapid-Acting Analog Insulin Absorption and Action for Both Subcutaneous Injection and Continuous Subcutaneous Infusion Using Recombinant Human Hyaluronidase

  2012cites this paper
• Aspectos básicos de la insulina aspart: ventajas potenciales derivadas de su mayor estabilidad fisicoquímica

  2012cites this paper
• Diabetestechnologie

  2012cites this paper
• Insulin therapy in children and adolescents.

  2012cites this paper
• Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations

  2012cites this paper
• Insulina aspart en terapia con perfusión subcutánea continua de insulina

  2012cites this paper
• Rapid-acting insulin glulisine: an update on clinical experience

  2011cites this paper
• Management of Diabetes Mellitus with Insulin Lispro

  2011cites this paper
• Present and Future of Insulin Therapy : Research Rationale for New Insulins

  year unknowncites this paper